담도암 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 이 기간에 예상되는 주요 동향에는 진단과 치료에 있어서의 기술적 진보, 면역 치료의 채용, 정밀의료에 대한 수요 증가, 치료 어프로치의 진화, 바이오마커에 근거한 치료의 진보 등이 있습니다.
비만의 유병률의 상승이 담도암 시장의 성장을 견인할 것으로 예측됩니다. 심리적 영향, 노화, 유전적, 생물학적 요인 등 여러 요인이 관여하고 있습니다. 또한 호르몬 균형과 대사를 방해하여 담도 내에 암이 발생하기 쉬운 환경을 만들어 냅니다. 예를 들어, 2023년 9월 미국 정부 기관인 질병통제예방센터(CDC)는 성인 비만율이 35% 이상인 주의 수가 2021년 19개 주에서 2022년 22개로 증가했다고 보고했습니다.
담도암 시장의 주요 기업은 치료 효과와 환자 결과를 개선하기 위해 고급 병용 요법을 개발하고 있습니다. 예를 들어, 2023년 11월 미국 기반 제약 회사인 Merck & Co. 는 국소 진행성 절제 불가능한 전이성 담도암(BTC) 환자 치료를 위해 젬시타빈 및 시스플라틴과 병용하는 키트루다(펨브롤리주맙)에 대해 미국 식품의약국(FDA)의 승인을 받았습니다. 이번 승인은 화학요법 단독요법 대비 사망 위험을 17% 감소시켜 전체 생존율을 통계적으로 유의미하게 개선한 것으로 입증된 3상 임상시험 KEYNOTE-966의 결과를 기반으로 이루어졌습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 담도암 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 담도암 시장 : 성장률 분석
- 세계의 담도암 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 담도암 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 담도암 전체 시장(TAM)
제6장 시장 세분화
- 세계의 담도암 시장 : 암 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 간내 담관암
- 간외 담관암
- 담낭암
- 세계의 담도암 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 화학 치료
- 표적 치료
- 면역 치료
- 세계의 담도암 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 전문 암 센터
- 외래수술센터(ASC)
- 기타 최종 사용자
- 세계의 담도암 시장 : 간내 담관암 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 말초 간내 담관암
- 간내 담관암
- 세계의 담도암 시장 : 간외 담관암 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 담관 주위 담관암
- 원위 담관암
- 세계의 담도암 시장 : 담낭암 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 담낭암
- 진행성 담낭암
제7장 지역별/국가별 분석
- 세계의 담도암 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 담도암 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 담도암 시장 : 경쟁 구도
- 담도암 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- F. Hoffmann-La Roche Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Bristol-Myers Squibb Company 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- AstraZeneca Plc
- Eli Lily and Company
- Boehringer Ingelheim International GmbH
- Eisai Co. Ltd.
- Servier Pharmaceuticals
- Jazz Pharmaceuticals plc
- Incyte Corporation
- BeiGene LTD.
- Zymeworks
- Basilea Pharmaceutica Ltd.
- Taiho Oncology Inc.
- RenovoRx Inc.
- TransThera Sciences Inc.
- QED Therapeutics Inc.
- Helsinn Group
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 담도암 시장(2029년) : 새로운 기회를 제공하는 국가
- 담도암 시장(2029년) : 새로운 기회를 제공하는 부문
- 담도암 시장(2029년) : 성장 전략
제36장 부록
KTH
Biliary tract cancer (BTC), also known as cholangiocarcinoma, is a rare malignancy that develops in the bile ducts, gallbladder, or ampulla of Vater. This cancer disrupts bile flow, which is essential for digestion and waste elimination. Research and treatment efforts focus on early detection, advancing therapeutic options, and improving survival rates for affected patients.
The primary types of biliary tract cancer include intrahepatic bile duct cancer, extrahepatic bile duct cancer, and gallbladder cancer. Intrahepatic cholangiocarcinoma is a rare liver cancer affecting the bile ducts, potentially leading to bile flow obstruction. Treatment options include chemotherapy, targeted therapy, and immunotherapy, catering to various end users such as hospitals, specialty cancer centers, ambulatory surgical centers, and others.
The biliary tract cancer market research report is one of a series of new reports from The Business Research Company that provides biliary tract cancer market statistics, including the biliary tract cancer industry global market size, regional shares, competitors with the biliary tract cancer market share, detailed biliary tract cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the biliary tract cancer industry. This biliary tract cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The biliary tract cancer market size has grown strongly in recent years. It will grow from $0.67 billion in 2024 to $0.72 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to the rising incidence of biliary tract cancer, increasing demand for effective therapies, a surge in risk factors such as obesity, an aging population, and greater investment in research and development.
The biliary tract cancer market size is expected to see strong growth in the next few years. It will grow to $0.95 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to lifestyle changes, increasing awareness, early detection initiatives, favorable reimbursement policies, and supportive government policies. Key trends expected during this period include technological advancements in diagnosis and treatment, the adoption of immunotherapy, rising demand for precision medicine, evolving treatment approaches, and advancements in biomarker-based therapies.
The rising prevalence of obesity is expected to drive the growth of the biliary tract cancer market. Obesity is a chronic medical condition characterized by excessive fat accumulation that negatively impacts health. Several factors contribute to the increasing obesity rates, including physical inactivity, psychological influences, aging, and genetic or biological factors. Obesity promotes chronic inflammation, insulin resistance, and excessive bile acid secretion, leading to DNA damage and tumor formation. It also disrupts hormonal balance and metabolism, creating a cancer-prone environment in the biliary tract. For example, in September 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that in 2022, the number of states with an adult obesity rate of 35% or higher increased to 22, up from 19 in 2021. As a result, the growing prevalence of obesity is fueling the expansion of the biliary tract cancer market.
Leading companies in the biliary tract cancer market are developing advanced combination therapies to improve treatment efficacy and patient outcomes. Combination therapy involves using two or more medications or treatment approaches simultaneously to enhance effectiveness. For instance, in November 2023, Merck & Co. Inc., a US-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for KEYTRUDA (pembrolizumab) in combination with gemcitabine and cisplatin for treating patients with locally advanced unresectable or metastatic biliary tract cancer (BTC). This approval was based on results from the Phase 3 KEYNOTE-966 trial, which demonstrated a statistically significant improvement in overall survival, reducing the risk of death by 17% compared to chemotherapy alone. Patients receiving the combination therapy had a median overall survival of 12.7 months, compared to 10.9 months for those on chemotherapy alone, marking a major advancement in treatment options for this challenging cancer.
In December 2022, Jazz Pharmaceuticals plc, an Ireland-based pharmaceutical company, partnered with Zymeworks Inc. to develop and commercialize zanidatamab, a HER2-targeted bispecific antibody. This collaboration was driven by promising results from the HERIZON-BTC-01 pivotal trial for biliary tract cancers. Zymeworks Inc. is a Canada-based biotechnology company specializing in the development of biliary tract cancer drugs.
Major players in the biliary tract cancer market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Eli Lily and Company, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Servier Pharmaceuticals, Jazz Pharmaceuticals plc, Incyte Corporation, BeiGene LTD., Zymeworks, Basilea Pharmaceutica Ltd., Taiho Oncology Inc., RenovoRx Inc., TransThera Sciences Inc., QED Therapeutics Inc., and Helsinn Group.
North America was the largest region in the biliary tract cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biliary tract cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the biliary tract cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biliary tract cancer market consists of revenues earned by entities by providing services such as diagnosis and screening services, supportive care, clinical trials, and research. The market value includes the value of related goods sold by the service provider or included within the service offering. The biliary tract cancer market also includes sales of surgical instruments, pain management medications, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biliary Tract Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biliary tract cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biliary tract cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biliary tract cancer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Cancer Type: Intrahepatic Bile Duct Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer
- 2) By Treatment: Chemotherapy; Targeted Therapy; Immunotherapy
- 3) By End-User: Hospitals; Specialty Cancer Centres; Ambulatory Surgical Centres; Other End-Users
- Subsegments:
- 1) By Intrahepatic Bile Duct Cancer: Peripheral Intrahepatic Bile Duct Cancer; Hilar Intrahepatic Bile Duct Cancer
- 2) By Extrahepatic Bile Duct Cancer: Perihilar Bile Duct Cancer; Distal Bile Duct Cancer
- 3) By Gallbladder Cancer: Localized Gallbladder Cancer; Advanced Gallbladder Cancer
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Bristol-Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biliary Tract Cancer Market Characteristics
3. Biliary Tract Cancer Market Trends And Strategies
4. Biliary Tract Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Biliary Tract Cancer Growth Analysis And Strategic Analysis Framework
- 5.1. Global Biliary Tract Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Biliary Tract Cancer Market Growth Rate Analysis
- 5.4. Global Biliary Tract Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Biliary Tract Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Biliary Tract Cancer Total Addressable Market (TAM)
6. Biliary Tract Cancer Market Segmentation
- 6.1. Global Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Intrahepatic Bile Duct Cancer
- Extrahepatic Bile Duct Cancer
- Gallbladder Cancer
- 6.2. Global Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- 6.3. Global Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Cancer Centres
- Ambulatory Surgical Centres
- Other End-Users
- 6.4. Global Biliary Tract Cancer Market, Sub-Segmentation Of Intrahepatic Bile Duct Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Peripheral Intrahepatic Bile Duct Cancer
- Hilar Intrahepatic Bile Duct Cancer
- 6.5. Global Biliary Tract Cancer Market, Sub-Segmentation Of Extrahepatic Bile Duct Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Perihilar Bile Duct Cancer
- Distal Bile Duct Cancer
- 6.6. Global Biliary Tract Cancer Market, Sub-Segmentation Of Gallbladder Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Localized Gallbladder Cancer
- Advanced Gallbladder Cancer
7. Biliary Tract Cancer Market Regional And Country Analysis
- 7.1. Global Biliary Tract Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Biliary Tract Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Biliary Tract Cancer Market
- 8.1. Asia-Pacific Biliary Tract Cancer Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Biliary Tract Cancer Market
- 9.1. China Biliary Tract Cancer Market Overview
- 9.2. China Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Biliary Tract Cancer Market
- 10.1. India Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Biliary Tract Cancer Market
- 11.1. Japan Biliary Tract Cancer Market Overview
- 11.2. Japan Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Biliary Tract Cancer Market
- 12.1. Australia Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Biliary Tract Cancer Market
- 13.1. Indonesia Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Biliary Tract Cancer Market
- 14.1. South Korea Biliary Tract Cancer Market Overview
- 14.2. South Korea Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Biliary Tract Cancer Market
- 15.1. Western Europe Biliary Tract Cancer Market Overview
- 15.2. Western Europe Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Biliary Tract Cancer Market
- 16.1. UK Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Biliary Tract Cancer Market
- 17.1. Germany Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Biliary Tract Cancer Market
- 18.1. France Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Biliary Tract Cancer Market
- 19.1. Italy Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Biliary Tract Cancer Market
- 20.1. Spain Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biliary Tract Cancer Market
- 21.1. Eastern Europe Biliary Tract Cancer Market Overview
- 21.2. Eastern Europe Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Biliary Tract Cancer Market
- 22.1. Russia Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Biliary Tract Cancer Market
- 23.1. North America Biliary Tract Cancer Market Overview
- 23.2. North America Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Biliary Tract Cancer Market
- 24.1. USA Biliary Tract Cancer Market Overview
- 24.2. USA Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Biliary Tract Cancer Market
- 25.1. Canada Biliary Tract Cancer Market Overview
- 25.2. Canada Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Biliary Tract Cancer Market
- 26.1. South America Biliary Tract Cancer Market Overview
- 26.2. South America Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Biliary Tract Cancer Market
- 27.1. Brazil Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Biliary Tract Cancer Market
- 28.1. Middle East Biliary Tract Cancer Market Overview
- 28.2. Middle East Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Biliary Tract Cancer Market
- 29.1. Africa Biliary Tract Cancer Market Overview
- 29.2. Africa Biliary Tract Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Biliary Tract Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Biliary Tract Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Biliary Tract Cancer Market Competitive Landscape And Company Profiles
- 30.1. Biliary Tract Cancer Market Competitive Landscape
- 30.2. Biliary Tract Cancer Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Biliary Tract Cancer Market Other Major And Innovative Companies
- 31.1. AstraZeneca Plc
- 31.2. Eli Lily and Company
- 31.3. Boehringer Ingelheim International GmbH
- 31.4. Eisai Co. Ltd.
- 31.5. Servier Pharmaceuticals
- 31.6. Jazz Pharmaceuticals plc
- 31.7. Incyte Corporation
- 31.8. BeiGene LTD.
- 31.9. Zymeworks
- 31.10. Basilea Pharmaceutica Ltd.
- 31.11. Taiho Oncology Inc.
- 31.12. RenovoRx Inc.
- 31.13. TransThera Sciences Inc.
- 31.14. QED Therapeutics Inc.
- 31.15. Helsinn Group
32. Global Biliary Tract Cancer Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Biliary Tract Cancer Market
34. Recent Developments In The Biliary Tract Cancer Market
35. Biliary Tract Cancer Market High Potential Countries, Segments and Strategies
- 35.1 Biliary Tract Cancer Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Biliary Tract Cancer Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Biliary Tract Cancer Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
